Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-039192)

Filing Details

Accession Number:: 0001209191-19-039192
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-26 20:40:24
Reporting Period:: 2019-06-26

Accepted Time:: 2019-06-26 20:40:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1689813	Biohaven Pharmaceutical Holding Co Ltd.	BHVN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1027035	W John Childs	C/O Biohaven Pharmaceuticals, Inc. 215 Church Street New Haven CT 06510		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2019-06-26	10,000	$40.37	10,000	No	4	P	Indirect	By John W Childs 2013 Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By John W Childs 2013 Revocable Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	2,826,938	Direct

Footnotes

Includes 2,719,438 shares that were previously held in the John W. Childs 2013 Revocable Trust, which are now held directly by the Reporting Person.